KVA

K V Pharma CL A (KVA)

K V Pharma CL A

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:KVA

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
06/18/2012	9:04AM	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVA	K V Pharma CL A
06/18/2012	7:08AM	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVA	K V Pharma CL A
11/16/2011	8:15PM	Business Wire	Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
11/02/2011	9:40PM	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
10/31/2011	9:30PM	Business Wire	Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
10/28/2011	4:30PM	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
10/24/2011	1:52PM	Business Wire	The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
10/20/2011	8:47PM	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
10/13/2011	9:02AM	Business Wire	Zeldes & Haeggquist, LLP Announces Investigation of K-V Pharmaceutical	NYSE:KVA	K V Pharma CL A
06/13/2011	8:00AM	PR Newswire (US)	K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call	NYSE:KVA	K V Pharma CL A
04/01/2011	3:08PM	Dow Jones News	UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry	NYSE:KVA	K V Pharma CL A
04/01/2011	10:28AM	Dow Jones News	K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move	NYSE:KVA	K V Pharma CL A
03/31/2011	5:28PM	Dow Jones News	Religious Groups Urge Drug Makers To Ease Up On Price Hikes	NYSE:KVA	K V Pharma CL A
03/30/2011	3:58PM	Dow Jones News	UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVA	K V Pharma CL A
03/30/2011	12:38PM	Dow Jones News	K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVA	K V Pharma CL A
03/01/2011	8:49AM	PR Newswire (US)	K-V Pharmaceutical Company Announces $200 Million Private Debt Offering	NYSE:KVA	K V Pharma CL A
02/14/2011	10:36AM	PR Newswire (US)	KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call Comments	NYSE:KVA	K V Pharma CL A
02/14/2011	10:34AM	PR Newswire (US)	K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue	NYSE:KVA	K V Pharma CL A
02/14/2011	9:48AM	PR Newswire (US)	K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock	NYSE:KVA	K V Pharma CL A
02/04/2011	8:40AM	PR Newswire (US)	K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011	NYSE:KVA	K V Pharma CL A
01/12/2011	9:03AM	PR Newswire (US)	K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™	NYSE:KVA	K V Pharma CL A
09/14/2010	10:29AM	Dow Jones News	K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval	NYSE:KVA	K V Pharma CL A
09/10/2010	9:53AM	Dow Jones News	K-V Pharma Soars On FDA Approval To Return Product To Market	NYSE:KVA	K V Pharma CL A
02/25/2010	1:53PM	PR Newswire (US)	KV Pharmaceutical Reaches Agreement with U.S. Department of Justice	NYSE:KVA	N^CURN
01/28/2010	5:04PM	Business Wire	Robbins Umeda LLP Announces Investigation of KV Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
01/20/2010	3:41PM	Dow Jones News	UPDATE: Watson Pharma Benefits From Toprol Market Presence	NYSE:KVA	K V Pharma CL A
01/20/2010	2:11PM	Dow Jones News	Watson Pharma Continues To Benefit From Toprol Market Presence	NYSE:KVA	K V Pharma CL A
01/11/2010	9:18AM	PR Newswire (US)	KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)	NYSE:KVA
01/07/2010	4:10PM	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director	NYSE:KVA
12/22/2009	5:34PM	PR Newswire (US)	KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010	NYSE:KVA